Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Songhui Li, Wenfeng Zhao, Lei Xia, Lingyi Kong & Lei Yang. (2023) How Long Will It Take to Launch an Effective Helicobacter pylori Vaccine for Humans?. Infection and Drug Resistance 16, pages 3787-3805.
Read now
Read now
Jinzhu Ma, Beiyan Wang, Liquan Yu, Baifen Song, Yongzhong Yu, Shuangshuang Wu, Yazun Dong, Zhanbo Zhu & Yudong Cui. (2020) The novel combinations of CTB, CpG, and aluminum hydroxide significantly enhanced the immunogenicity of clumping factor A 221-550 of Staphylococcus aureus. Bioscience, Biotechnology, and Biochemistry 84:9, pages 1846-1855.
Read now
Read now
Holly Sanders & Ian M Feavers. (2011) Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines. Expert Review of Vaccines 10:3, pages 323-334.
Read now
Read now
Derek T O’Hagan. (2007) MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection. Expert Review of Vaccines 6:5, pages 699-710.
Read now
Read now
Heather L. Wilson, Arshud Dar, Scott K. Napper, A. Marianela Lopez, Lorne A. Babiuk & George K. Mutwiri. (2006) Immune Mechanisms and Therapeutic Potential of CpG Oligodeoxynucleotides. International Reviews of Immunology 25:3-4, pages 183-213.
Read now
Read now
Jörg Vollmer. (2006) TLR9 in Health and Disease. International Reviews of Immunology 25:3-4, pages 155-181.
Read now
Read now
Jörg Vollmer. (2005) Progress in drug development of immunostimulatory CpG oligodeoxynucleotide ligands for TLR9. Expert Opinion on Biological Therapy 5:5, pages 673-682.
Read now
Read now
Nelson S Yew & Seng H Cheng. (2004) Reducing the immunostimulatory activity of CpG-containing plasmid DNA vectors for non-viral gene therapy. Expert Opinion on Drug Delivery 1:1, pages 115-125.
Read now
Read now
Articles from other publishers (61)
Yao Hu, Zhongxu Luo, Zhilei Ge, Qian Li, Peihui Yang, Honglu Zhang & Huan Zhang. (2023) Morphology Dictated Immune Activation with Framework Nucleic Acids. Small 19:48.
Crossref
Crossref
Muhammet Karakavuk, Hüseyin Can, Aytül Gül, Aysu Değirmenci Döşkaya, Sedef Erkunt Alak, Cemal Ün, Adnan Yüksel Gürüz & Mert Döşkaya. (2021) GRA8 DNA vaccine formulations protect against chronic toxoplasmosis. Microbial Pathogenesis 158, pages 105016.
Crossref
Crossref
Jinzhu Ma, Wei Liu, Beiyan Wang, Simiao Yu, Liquan Yu, Baifen Song, Yongzhong Yu, Zhanbo Zhu & Yudong Cui. (2021)
Als3‐Th‐cell‐epitopes plus the novel combined adjuvants of CpG, MDP, and FIA synergistically enhanced the immune response of recombinant TRAP derived from
Staphylococcus aureus
in mice
. Immunity, Inflammation and Disease 9:3, pages 971-983.
Crossref
Crossref
Ivana Ruseska, Katja Fresacher, Christina Petschacher & Andreas Zimmer. (2021) Use of Protamine in Nanopharmaceuticals—A Review. Nanomaterials 11:6, pages 1508.
Crossref
Crossref
Ekaterina A. Golenkina, Svetlana I. Galkina, Nina G. Dolinnaya, Evgenii A. Arifulin, Yulia M. Romanova & Galina F. Sud’ina. (2021) Synthetic Hexanucleotides as a Tool to Overcome Excessive Neutrophil Activation Caused by CpG-Containing Oligonucleotides. Pathogens 10:5, pages 530.
Crossref
Crossref
Xiaoli Sun & Haipeng Liu. (2020) Nucleic Acid Nanostructure Assisted Immune Modulation. ACS Applied Bio Materials 3:5, pages 2765-2778.
Crossref
Crossref
Seth G Thacker, Ian L. McWilliams, Beatrice Bonnet, Lydia Halie, Serge Beaucage, Swaksha Rachuri, Ranadhir Dey, Robert Duncan, Farrokh Modabber, Stephen Robinson, Graeme Bilbe, Byron Arana & Daniela Verthelyi. (2020) CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis. PLOS Neglected Tropical Diseases 14:2, pages e0008050.
Crossref
Crossref
Mohanraj Manangeeswaran, Aaron P. Lewkowicz, Tomer Israely, Derek D.C. Ireland & Daniela Verthelyi. (2020) CpG Oligonucleotides Protect Mice From Alphavirus Encephalitis: Role of NK Cells, Interferons, and TNF. Frontiers in Immunology 11.
Crossref
Crossref
Jiana Jiang, Xianming Kong, Yuexia Xie, Hanbing Zou, Qianyun Tang, Ding Ma, Xue Zhao, Xiaozhen He, Anyue Xia & Peifeng Liu. (2019) Potent anti-tumor immunostimulatory biocompatible nanohydrogel made from DNA. Nanoscale Research Letters 14:1.
Crossref
Crossref
Krisztina Fehér. (2019) Single Stranded DNA Immune Modulators with Unmethylated CpG Motifs: Structure and Molecular Recognition by Toll-Like Receptor 9. Current Protein & Peptide Science 20:11, pages 1060-1068.
Crossref
Crossref
Sakineh Pirahmadi, Sedigheh Zakeri, Akram A. Mehrizi, Navid D. Djadid, Abbas-Ali Raz & Jafar J. Sani. (2019) Combining Monophosphoryl Lipid A (MPL), CpG Oligodeoxynucleotide (ODN), and QS-21 Adjuvants Induces Strong and Persistent Functional Antibodies and T Cell Responses against Cell-Traversal Protein for Ookinetes and Sporozoites (CelTOS) of Plasmodium falciparum in BALB/c Mice. Infection and Immunity 87:6.
Crossref
Crossref
Jinzhu Ma, Liquan Yu, Baifen Song, Yongzhong Yu, Shaoduo Zhang, Yuhua Wei, Zhijun Wu, Di Yao, Wei Yu, Zhanbo Zhu & Yudong Cui. (2018) The double adjuvants LTB and CpG significantly enhanced the immuno-protective effects of recombinant GIT derived from Staphylococcus aureus and Streptococcus in mice. Journal of Medical Microbiology 67:3, pages 432-440.
Crossref
Crossref
Emilia Pachulec, Rym Ben Abdelwahed Bagga, Lucie Chevallier, Hope O’Donnell, Chloé Guillas, Jean Jaubert, Xavier Montagutelli, Elisabeth Carniel & Christian E Demeure. (2017) Enhanced Macrophage M1 Polarization and Resistance to Apoptosis Enable Resistance to Plague. The Journal of Infectious Diseases 216:6, pages 761-770.
Crossref
Crossref
Huijie Zhang & Xiao-Dong Gao. (2017) Nanodelivery systems for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides. Materials Science and Engineering: C 70, pages 935-946.
Crossref
Crossref
Angeliki Tiptiri-Kourpeti, Katerina Spyridopoulou, Aglaia Pappa & Katerina Chlichlia. (2016) DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy. Pharmacology & Therapeutics 165, pages 32-49.
Crossref
Crossref
Signe Tandrup Schmidt, Camilla Foged, Karen Smith Korsholm, Thomas Rades & Dennis Christensen. (2016) Liposome-Based Adjuvants for Subunit Vaccines: Formulation Strategies for Subunit Antigens and Immunostimulators. Pharmaceutics 8:1, pages 7.
Crossref
Crossref
Juliana de Souza Apostólico, Victória Alves Santos Lunardelli, Fernanda Caroline Coirada, Silvia Beatriz Boscardin & Daniela Santoro Rosa. (2016)
Adjuvants: Classification,
Modus Operandi
, and Licensing
. Journal of Immunology Research 2016, pages 1-16.
Crossref
Crossref
Takeshi Kinjo, Koji Tomaru, Diana C Haines & Dennis M Klinman. (2012) The counter regulatory response induced by CpG oligonucleotides prevents bleomycin induced pneumopathy. Respiratory Research 13:1.
Crossref
Crossref
George Mutwiri. (2012) TLR9 agonists: Immune mechanisms and therapeutic potential in domestic animals. Veterinary Immunology and Immunopathology 148:1-2, pages 85-89.
Crossref
Crossref
Vahid Heravi Shargh, Mahmoud Reza Jaafari, Ali Khamesipour, Seyed Amir Jalali, Hengameh Firouzmand, Azam Abbasi & Ali Badiee. (2012) Cationic liposomes containing soluble Leishmania antigens (SLA) plus CpG ODNs induce protection against murine model of leishmaniasis. Parasitology Research 111:1, pages 105-114.
Crossref
Crossref
Vahid Heravi Shargh, Mahmoud Reza Jaafari, Ali Khamesipour, Iman Jaafari, Seyed Amir Jalali, Azam Abbasi & Ali Badiee. (2012) Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis. Vaccine 30:26, pages 3957-3964.
Crossref
Crossref
Ayman Al-Mariri, Nermeen Haj Mahmoud & Razan Hammoud. (2012) Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB/c mice. Biologicals 40:2, pages 140-145.
Crossref
Crossref
Stéphanie Ferret-Bernard, Sonia Lacroix-Lamandé, Aude Remot, Coralie Metton, Nelly Bernardet, Bernard Charley, Françoise Drouet & Fabrice Laurent. (2011) Mesenteric lymph node cells from neonates present a prominent IL-12 response to CpG oligodeoxynucleotide via an IL-15 feedback loop of amplification. Veterinary Research 42:1.
Crossref
Crossref
David B. Lewis & Christopher B. Wilson. 2011. Infectious Diseases of the Fetus and Newborn. Infectious Diseases of the Fetus and Newborn
80
191
.
Anil K. Nichani, M. Arshad Dar, Kuldip K. Mirakhur, Arthur M. Krieg, Jayaum S. Booth, Hugh G.G. Townsend, Andrew A. Potter, Lorne A. Babiuk & George K. Mutwiri. (2010) Subcutaneous, but not intratracheal administration of the TLR9 agonist, CpG DNA transiently reduces parainfluenza-3 virus shedding in newborn lambs. Comparative Immunology, Microbiology and Infectious Diseases 33:6, pages e111-e117.
Crossref
Crossref
Jörg Vollmer. 2010. Predictive Toxicology in Drug Safety. Predictive Toxicology in Drug Safety
124
134
.
Jörg Vollmer. 2010. Emerging Cancer Therapy. Emerging Cancer Therapy
379
401
.
Derek O?Hagan. 2009. New Generation Vaccines, Fourth Edition. New Generation Vaccines, Fourth Edition
284
297
.
Jin-ming Di, Jun Pang, Xiao-yong Pu, Yan Zhang, Xiao-peng Liu, You-qiang Fang, Xing-xing Ruan & Xin Gao. (2009) Toll-like receptor 9 agonists promote IL-8 and TGF-β1production via activation of nuclear factor κB in PC-3 cells. Cancer Genetics and Cytogenetics 192:2, pages 60-67.
Crossref
Crossref
Kei Amemiya, Jennifer L. Meyers, Taralyn E. Rogers, Randy L. Fast, Anthony D. Bassett, Patricia L. Worsham, Bradford S. Powell, Sarah L. Norris, Arthur M. Krieg & Jeffrey J. Adamovicz. (2009) CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague. Vaccine 27:16, pages 2220-2229.
Crossref
Crossref
Valentin Vlassov, Dmitrii Pyshnyi & Pavel Vorobjev. 2009. Handbook of Nucleic Acid Purification. Handbook of Nucleic Acid Purification.
Nir Peled, Ana B Oton, Fred R Hirsch & Paul Bunn. (2009) MAGE A3 antigen-specific cancer immunotherapeutic. Immunotherapy 1:1, pages 19-25.
Crossref
Crossref
Deidra A. Blanks & Charles S. EbertJrJr. (2008) Immune modulatory oligonucleotides in the prevention and treatment of allergen-induced eustachian tube dysfunction in the animal model. Current Allergy and Asthma Reports 8:6.
Crossref
Crossref
Dennis Klinman, Hidekazu Shirota, Debra Tross, Takashi Sato & Sven Klaschik. (2008) Synthetic oligonucleotides as modulators of inflammation. Journal of Leukocyte Biology 84:4, pages 958-964.
Crossref
Crossref
Xiaocong Yu, Patricia A. McGraw, Frances S. House & James E. CroweJr.Jr.. (2008) An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. Journal of Immunological Methods 336:2, pages 142-151.
Crossref
Crossref
João A. Pedras-Vasconcelos, Montserrat Puig, Christian Sauder, Candie Wolbert, Mikhail Ovanesov, David Goucher & Daniela Verthelyi. (2008) Immunotherapy with CpG Oligonucleotides and Antibodies to TNF-α Rescues Neonatal Mice from Lethal Arenavirus-Induced Meningoencephalitis. The Journal of Immunology 180:12, pages 8231-8240.
Crossref
Crossref
Arshud Dar, Anil K. Nichani, Ponn Benjamin, Ken Lai, Henry Soita, Arthur M. Krieg, Andrew Potter, Lorne A. Babiuk & George K. Mutwiri. (2008) Attenuated cytokine responses in porcine lymph node cells stimulated with CpG DNA are associated with low frequency of IFNα-producing cells and TLR9 mRNA expression. Veterinary Immunology and Immunopathology 123:3-4, pages 324-336.
Crossref
Crossref
Montserrat Puig & Daniela Verthelyi. 2008. Nucleic Acids in Innate Immunity. Nucleic Acids in Innate Immunity
113
128
.
Eugen Uhlmann. 2008. Therapeutic Oligonucleotides. Therapeutic Oligonucleotides
142
162
.
Ali Badiee, Mahmoud R. Jaafari, Afshin Samiei, Dina Soroush & Ali Khamesipour. (2008)
Coencapsulation of CpG Oligodeoxynucleotides with Recombinant
Leishmania major
Stress-Inducible Protein 1 in Liposome Enhances Immune Response and Protection against Leishmaniasis in Immunized BALB/c Mice
. Clinical and Vaccine Immunology 15:4, pages 668-674.
Crossref
Crossref
Haruki KITAZAWA, Masanori TOHNO, Takeshi SHIMOSATO & Tadao SAITO. (2007) Development of molecular immunoassay system for probiotics via toll-like receptors based on food immunology. Animal Science Journal 79:1, pages 11-21.
Crossref
Crossref
Lu Lu, Yun Zhu, Junchen Diao, Zuguang Wang & Ying-Hua Chen. (2008) V3 CTL epitope density in a single recombinant molecule antigen differentially affects the number and activity of primary and memory CD8+ T cells. Vaccine 26:6, pages 845-852.
Crossref
Crossref
CHARLES S. EBERT & HAROLD C. PILLSBURY. 2008. Managing the Allergic Patient. Managing the Allergic Patient
175
191
.
Derek T. O’Hagan & Audino Podda. 2008. Influenza Vaccines for the Future. Influenza Vaccines for the Future
221
244
.
John G. VoellerTerry C. Pellmar. 2008. Wiley Handbook of Science and Technology for Homeland Security. Wiley Handbook of Science and Technology for Homeland Security
1
27
.
Corinna Hermann. (2016) Review: Variability of host—pathogen interaction. Journal of Endotoxin Research 13:4, pages 199-218.
Crossref
Crossref
Deidra A. Blanks, Charles S. EbertJrJr, Rose P. Eapen, Carlton Zdanski, Ekambar R. Kandimalla, Sudhir Agrawal & Jiri Prazma. (2016) Immune Modulatory Oligonucleotides in the Prevention and Treatment of OVA‐Induced Eustachian Tube Dysfunction in Rats. Otolaryngology–Head and Neck Surgery 137:2, pages 321-326.
Crossref
Crossref
Anil K. Nichani, M. Arshud Dar, Arthur M. Krieg, Kuldip K. Mirakhur, Radhey S. Kaushik, Philip J. Griebel, Anju Manuja, Hugh G.G. Townsend, Lorne A. Babiuk & George K. Mutwiri. (2007) Systemic innate immune responses following intrapulmonary delivery of CpG oligodeoxynucleotides in sheep. Veterinary Immunology and Immunopathology 115:3-4, pages 357-368.
Crossref
Crossref
Charles S. EbertJr.Jr., Austin S. Rose, Mihir R. Patel, Stuart M. Hardy, Ekambar R. Kandimalla, Sudhir Agrawal, Jiri Prazma & Harold C. PillsburyIIIIII. (2006) The role of immunomodulatory oligonucleotides in prevention of OVA-induced Eustachian tube dysfunction. International Journal of Pediatric Otorhinolaryngology 70:12, pages 2019-2026.
Crossref
Crossref
Haiqi He, Kenneth J. Genovese, Virginia K. Lowry, David J. Nisbet & Michael H. Kogut. (2006) Response of nitric oxide production to CpG oligodeoxynucleotides in turkey and chicken peripheral blood monocytes. FEMS Immunology & Medical Microbiology 48:1, pages 99-106.
Crossref
Crossref
Lou Ann S. Brown, Robert T. Cook, Thomas R. Jerrells, Jay K. Kolls, Laura E. Nagy, Gyongyi Szabo, Jack R. Wands & Elizabeth J. Kovacs. (2006) Acute and Chronic Alcohol Abuse Modulate Immunity. Alcoholism: Clinical and Experimental Research 30:9, pages 1624-1631.
Crossref
Crossref
N. N. Veiko, N. O. Shubaeva, S. M. Ivanova, A. I. Speranskii, N. A. Lyapunova & D. M. Spitkovskii. (2006) Blood serum DNA in patients with rheumatoid arthritis is considerably enriched with fragments of ribosomal repeats containing immunostimulatory CpG-motifs. Bulletin of Experimental Biology and Medicine 142:3, pages 313-316.
Crossref
Crossref
Arthur M. Krieg. (2006) Therapeutic potential of Toll-like receptor 9 activation. Nature Reviews Drug Discovery 5:6, pages 471-484.
Crossref
Crossref
João A. Pedras-Vasconcelos, David Goucher, Montserrat Puig, Leonardo H. Tonelli, Vivian Wang, Shuichi Ito & Daniela Verthelyi. (2006) CpG Oligodeoxynucleotides Protect Newborn Mice from a Lethal Challenge with the Neurotropic Tacaribe Arenavirus. The Journal of Immunology 176:8, pages 4940-4949.
Crossref
Crossref
Alexandre Carpentier, Florence Laigle-Donadey, Sarah Zohar, Laurent Capelle, Anthony Behin, Annick Tibi, Nadine Martin-Duverneuil, Marc Sanson, Lucette Lacomblez, Sophie Taillibert, Louis Puybasset, Remy Van Effenterre, Jean-Yves Delattre & Antoine F. Carpentier. (2006) Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma1. Neuro-Oncology 8:1, pages 60-66.
Crossref
Crossref
M. J. McCluskie & A. M. Krieg. 2006. From Innate Immunity to Immunological Memory. From Innate Immunity to Immunological Memory
155
178
.
Philip J. Griebel, Robert Brownlie, Anju Manuja, Anil Nichani, Neeloffer Mookherjee, Yurij Popowych, George Mutwiri, Rolf Hecker & Lorne A. Babiuk. (2005) Bovine toll-like receptor 9: A comparative analysis of molecular structure, function and expression. Veterinary Immunology and Immunopathology 108:1-2, pages 11-16.
Crossref
Crossref
Geanncarlo Lugo-Villarino, Shu-Ichi Ito, Dennis M. Klinman & Laurie H. Glimcher. (2005) The adjuvant activity of CpG DNA requires T-bet expression in dendritic cells. Proceedings of the National Academy of Sciences 102:37, pages 13248-13253.
Crossref
Crossref
Barbara Flynn, Vivian WangDavid L. Sacks, Robert A Seder & Daniela Verthelyi. (2005) Prevention and Treatment of Cutaneous Leishmaniasis in Primates by Using Synthetic Type D/A Oligodeoxynucleotides Expressing CpG Motifs. Infection and Immunity 73:8, pages 4948-4954.
Crossref
Crossref
Haruki Kitazawa, Takeshi Shimosato, Masanori Tohno & Tadao Saito. (2005) Immunostimulatory Activities of Lactic Acid Bacteria via Toll-like Receptors. Japanese Journal of Lactic Acid Bacteria 16:1, pages 11-20.
Crossref
Crossref
Eicke Latz, Alberto Visintin, Terje Espevik & Douglas T. Golenbock. (2016) Mechanisms of TLR9 activation. Journal of Endotoxin Research 10:6, pages 406-412.
Crossref
Crossref